JP2004506010A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004506010A5 JP2004506010A5 JP2002518951A JP2002518951A JP2004506010A5 JP 2004506010 A5 JP2004506010 A5 JP 2004506010A5 JP 2002518951 A JP2002518951 A JP 2002518951A JP 2002518951 A JP2002518951 A JP 2002518951A JP 2004506010 A5 JP2004506010 A5 JP 2004506010A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- substituted
- unsubstituted
- alkyl
- unbranched
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 description 22
- 125000000217 alkyl group Chemical group 0.000 description 14
- 125000001424 substituent group Chemical group 0.000 description 12
- 125000003118 aryl group Chemical group 0.000 description 6
- 125000000623 heterocyclic group Chemical group 0.000 description 6
- LSBDFXRDZJMBSC-UHFFFAOYSA-N Amide-Phenylacetic acid Natural products NC(=O)CC1=CC=CC=C1 LSBDFXRDZJMBSC-UHFFFAOYSA-N 0.000 description 5
- ALDSXDRDRWDASQ-UHFFFAOYSA-N 2-(3-benzoylphenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 ALDSXDRDRWDASQ-UHFFFAOYSA-N 0.000 description 4
- -1 3-benzoylphenyl Chemical group 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 208000015122 neurodegenerative disease Diseases 0.000 description 4
- WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical compound OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 description 4
- 210000001525 retina Anatomy 0.000 description 3
- XAARRDGAECXQPW-UHFFFAOYSA-N 2-[2-amino-3-(4-fluorobenzoyl)phenyl]acetamide Chemical group NC(=O)CC1=CC=CC(C(=O)C=2C=CC(F)=CC=2)=C1N XAARRDGAECXQPW-UHFFFAOYSA-N 0.000 description 2
- 125000000242 4-chlorobenzoyl group Chemical group ClC1=CC=C(C(=O)*)C=C1 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000010253 intravenous injection Methods 0.000 description 2
- 210000003733 optic disk Anatomy 0.000 description 2
- 229960003424 phenylacetic acid Drugs 0.000 description 2
- 239000003279 phenylacetic acid Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- 208000031104 Arterial Occlusive disease Diseases 0.000 description 1
- 206010012689 Diabetic retinopathy Diseases 0.000 description 1
- 206010061323 Optic neuropathy Diseases 0.000 description 1
- 208000002367 Retinal Perforations Diseases 0.000 description 1
- 208000017442 Retinal disease Diseases 0.000 description 1
- 208000007014 Retinitis pigmentosa Diseases 0.000 description 1
- 206010038923 Retinopathy Diseases 0.000 description 1
- 206010038935 Retinopathy sickle cell Diseases 0.000 description 1
- 206010058990 Venous occlusion Diseases 0.000 description 1
- 208000021328 arterial occlusion Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000000642 iatrogenic effect Effects 0.000 description 1
- 208000002780 macular degeneration Diseases 0.000 description 1
- QEFAQIPZVLVERP-UHFFFAOYSA-N nepafenac Chemical compound NC(=O)CC1=CC=CC(C(=O)C=2C=CC=CC=2)=C1N QEFAQIPZVLVERP-UHFFFAOYSA-N 0.000 description 1
- 208000020911 optic nerve disease Diseases 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22513200P | 2000-08-14 | 2000-08-14 | |
| PCT/US2001/025319 WO2002013805A2 (en) | 2000-08-14 | 2001-08-13 | Method of treating neurodegenerative disorders of the retina and optic nerve head |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004506010A JP2004506010A (ja) | 2004-02-26 |
| JP2004506010A5 true JP2004506010A5 (enExample) | 2008-08-07 |
Family
ID=22843666
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002518951A Pending JP2004506010A (ja) | 2000-08-14 | 2001-08-13 | 網膜および視神経乳頭の神経変性障害を処置する方法 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US6638976B2 (enExample) |
| EP (1) | EP1309322B1 (enExample) |
| JP (1) | JP2004506010A (enExample) |
| AR (1) | AR030346A1 (enExample) |
| AT (1) | ATE330596T1 (enExample) |
| AU (1) | AU8125801A (enExample) |
| BR (1) | BR0113201A (enExample) |
| CA (1) | CA2418059C (enExample) |
| CY (1) | CY1106155T1 (enExample) |
| DE (1) | DE60120990T2 (enExample) |
| DK (1) | DK1309322T3 (enExample) |
| ES (1) | ES2266229T3 (enExample) |
| MX (1) | MXPA03001160A (enExample) |
| PT (1) | PT1309322E (enExample) |
| TW (1) | TWI286933B (enExample) |
| WO (1) | WO2002013805A2 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040132773A1 (en) * | 2001-08-13 | 2004-07-08 | Gamache Daniel A | Method of treating neurodgenerative disorders of the retina and optic nerve head |
| WO2004112772A1 (en) * | 2003-06-13 | 2004-12-29 | Alcon, Inc. | Formulations of non-steroidal anti-inflammatory agents to treat pathologic ocular angiogenesis |
| US20050009910A1 (en) * | 2003-07-10 | 2005-01-13 | Allergan, Inc. | Delivery of an active drug to the posterior part of the eye via subconjunctival or periocular delivery of a prodrug |
| TWI358290B (en) | 2004-12-02 | 2012-02-21 | Alcon Inc | Topical nepafenac formulations |
| WO2006121963A2 (en) * | 2005-05-10 | 2006-11-16 | Alcon, Inc. | Suspension formulations comprising an active principle, a poloxamer or meroxapol surfactant and a glycol, its use for the manufacture of a medicament for treating ophthalmic disorders |
| SI1906916T1 (sl) * | 2005-05-10 | 2009-02-28 | Alcon Inc | Oftalmična suspenzija, ki obsega oftalmično zdravilo, poloksamin in glikolno sredstvo za naravnavo toničnosti, uporaba sestavka za pripravo zdravila za zdravljenje oftalmičnih motenj |
| US8915877B2 (en) | 2010-10-12 | 2014-12-23 | Emmett T. Cunningham, JR. | Glaucoma drainage device and uses thereof |
| US9370444B2 (en) | 2010-10-12 | 2016-06-21 | Emmett T. Cunningham, JR. | Subconjunctival conformer device and uses thereof |
| RU2458656C1 (ru) * | 2011-06-17 | 2012-08-20 | Федеральное государственное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова Федерального агентства по высокотехнологичной медицинской помощи" | Способ лечения оперированного незакрывшегося макулярного отверстия |
| WO2014207769A1 (en) | 2013-06-27 | 2014-12-31 | Mylan Laboratories Ltd | Process for the preparation of nepafenac |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1226344A (enExample) | 1967-07-31 | 1971-03-24 | ||
| SE400966B (sv) | 1975-08-13 | 1978-04-17 | Robins Co Inc A H | Forfarande for framstellning av 2-amino-3-(eller 5-)bensoyl-fenylettiksyror |
| US4313949A (en) * | 1979-09-26 | 1982-02-02 | A. H. Robins Company, Inc. | Method of producing an inhibitory effect on blood platelet aggregation |
| US4254146A (en) * | 1979-10-18 | 1981-03-03 | A. H. Robins Company, Inc. | 3-Benzoyl-2-nitrophenylacetic acids, metal salts, amides and esters |
| IL61945A (en) * | 1980-02-19 | 1984-09-30 | Robins Co Inc A H | 2-amino-3-(hydroxy(phenyl)methyl)phenylacetic acids,esters and amides and pharmaceutical compositions containing them |
| DE3026402A1 (de) * | 1980-07-11 | 1982-02-04 | Syntex Corp., Palo Alto, Calif. | Die verwendung analgetischer und nicht-hormonaler, entzuendungshemmender mittel bei der behandlung von mikrovaskulaeren erkrankungen |
| US4503073A (en) * | 1981-01-07 | 1985-03-05 | A. H. Robins Company, Incorporated | 2-Amino-3-(alkylthiobenzoyl)-phenylacetic acids |
| IL64724A0 (en) | 1981-02-17 | 1982-03-31 | Robins Co Inc A H | 2-amino-3-(halobenzoyl)-methylphenylacetic acids and esters and salts thereof and pharmaceutical compositions containing them |
| US4454151A (en) | 1982-03-22 | 1984-06-12 | Syntex (U.S.A.) Inc. | Use of pyrrolo pyrroles in treatment of ophthalmic diseases |
| US4568695A (en) | 1983-12-07 | 1986-02-04 | A. H. Robins Company, Incorporated | 2-Amino-3-benzoyl-phenethylalcohols and intermediates therefor |
| US4851443A (en) | 1985-03-14 | 1989-07-25 | Smith Kline Dauelsberg, Gmbh | Carboxylic acid amides, compositions and medical use thereof |
| DE3668450D1 (de) | 1985-03-14 | 1990-03-01 | Smithkline Dauelsberg | 5-aminosalicylsaeurederivate von nicht-steroidalen entzuendungshemmenden sauren. |
| US4683242A (en) | 1985-10-28 | 1987-07-28 | A. H. Robins Company, Incorporated | Transdermal treatment for pain and inflammation with 2-amino-3-aroylbenzeneacetic acids, salts and esters |
| DK406686D0 (da) | 1986-08-26 | 1986-08-26 | Hans Bundgaard | Carboxylsyrederivater |
| US4910225A (en) | 1988-01-27 | 1990-03-20 | Senju Pharmaceutical Co., Ltd. | Locally administrable therapeutic composition for inflammatory disease |
| US5314909A (en) | 1993-03-17 | 1994-05-24 | Merck & Co., Inc. | Use of non-steroidal antiiflammatory agents in macular degeneration |
| JP3396953B2 (ja) | 1994-05-10 | 2003-04-14 | 千寿製薬株式会社 | 網膜疾患予防・治療剤 |
| US5475034A (en) * | 1994-06-06 | 1995-12-12 | Alcon Laboratories, Inc. | Topically administrable compositions containing 3-benzoylphenylacetic acid derivatives for treatment of ophthalmic inflammatory disorders |
| US5643943A (en) * | 1994-12-23 | 1997-07-01 | Alcon Laboratories, Inc. | Systemic administration of esters and amides of antioxidants which may be used as antioxidant prodrug therapy for oxidative and inflammatory pathogenesis |
| US5811446A (en) * | 1997-04-18 | 1998-09-22 | Cytos Pharmaceuticals Llc | Prophylactic and therapeutic methods for ocular degenerative diseases and inflammations and histidine compositions therefor |
| US6025353A (en) | 1997-11-19 | 2000-02-15 | G.D. Searle & Co. | Method of using cyclooxygenase-2 inhibitors as anti-angiogenic agents |
| US6066671A (en) * | 1997-12-19 | 2000-05-23 | Alcon Laboratories, Inc. | Treatment of GLC1A glaucoma with 3-benzoyl-phenylacetic acids, esters, or amides |
| JP2002534361A (ja) | 1999-01-07 | 2002-10-15 | バンダービルト・ユニバーシティ | Ｃｏｘ−２選択的阻害剤ではないｃｏｘ阻害化合物から、ｃｏｘ−２選択的阻害剤への変換 |
| US6413965B1 (en) | 1999-06-30 | 2002-07-02 | Pfizer Inc. | Compositions and treatment for diabetic complications |
| US6555540B1 (en) | 1999-06-30 | 2003-04-29 | Pfizer Inc | Combinations of aldose reductase inhibitors and selective cyclooxygenase-2 inhibitors |
| US6426341B1 (en) | 1999-06-30 | 2002-07-30 | Pfizer Inc. | Treatment for diabetic complications |
| US6416777B1 (en) | 1999-10-21 | 2002-07-09 | Alcon Universal Ltd. | Ophthalmic drug delivery device |
-
2001
- 2001-08-10 AR ARP010103847A patent/AR030346A1/es not_active Application Discontinuation
- 2001-08-13 EP EP01959734A patent/EP1309322B1/en not_active Expired - Lifetime
- 2001-08-13 BR BRPI0113201-6A patent/BR0113201A/pt not_active Application Discontinuation
- 2001-08-13 JP JP2002518951A patent/JP2004506010A/ja active Pending
- 2001-08-13 ES ES01959734T patent/ES2266229T3/es not_active Expired - Lifetime
- 2001-08-13 PT PT01959734T patent/PT1309322E/pt unknown
- 2001-08-13 AT AT01959734T patent/ATE330596T1/de active
- 2001-08-13 WO PCT/US2001/025319 patent/WO2002013805A2/en not_active Ceased
- 2001-08-13 TW TW090119751A patent/TWI286933B/zh not_active IP Right Cessation
- 2001-08-13 DE DE60120990T patent/DE60120990T2/de not_active Expired - Lifetime
- 2001-08-13 AU AU8125801A patent/AU8125801A/xx not_active Withdrawn
- 2001-08-13 MX MXPA03001160A patent/MXPA03001160A/es active IP Right Grant
- 2001-08-13 CA CA002418059A patent/CA2418059C/en not_active Expired - Fee Related
- 2001-08-13 US US09/929,704 patent/US6638976B2/en not_active Expired - Lifetime
- 2001-08-13 DK DK01959734T patent/DK1309322T3/da active
-
2006
- 2006-09-08 CY CY20061101289T patent/CY1106155T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012193214A (ja) | ベンゾイルフェニル酢酸を使用して、血管形成関連障害を処置するための方法 | |
| JP2013541527A (ja) | 網膜疾患を治療するための［３−（１−（１ｈ−イミダゾール４−イル）エチル）−２−メチルフェニル］メタノールのエステル・プロドラッグ | |
| JP2004506010A5 (enExample) | ||
| US6455567B1 (en) | Method of treatment | |
| JP2004520267A5 (enExample) | ||
| US6638976B2 (en) | Method of treating neurodegenerative disorders of the retina and optic nerve head | |
| JP2008514709A (ja) | 眼科疾患を治療するための組成物および方法 | |
| US6646003B2 (en) | Method of treating ocular inflammatory and angiogenesis-related disorders of the posterior segment of the eye using an amide derivative of flurbiprofen or ketorolac | |
| AU2001283337A1 (en) | Method of treating angiogenesis-related disorders using benzoyl phenylacetic acid | |
| ES2340786T3 (es) | Acido 5,6,7-trihidroxiheptanoico y analogos para el tratamiento de enfermedades oculares y enfermedades asociadas a las respuestas angiogenicas e hiperproliferativas. | |
| WO1997041864A1 (en) | Ophthalmic preparations | |
| JP2000086629A (ja) | 新規な酸化窒素放出化合物 | |
| JP5469707B2 (ja) | 脳梗塞に関連する脳血管障害の治療に有用なピラゾロン化合物 | |
| US20040132773A1 (en) | Method of treating neurodgenerative disorders of the retina and optic nerve head | |
| JP2010513262A5 (enExample) | ||
| AU2001281258B2 (en) | Method of treating neurodegenerative disorders of the retina and optic nerve head | |
| US20030187072A1 (en) | Method of treating angiogenesis-related disorders | |
| AU2006217547A1 (en) | Method of treating angiogenesis-related disorders | |
| AU2001281258A1 (en) | Method of treating neurodegenerative disorders of the retina and optic nerve head | |
| HK1057331B (en) | Treatment of angiogenesis-related disorders using benzoyl phenylacetic acid derivatives | |
| HK1057332B (en) | Use of 3-benzoylphenylacetic acid derivatives for the treatment of retinal disorders | |
| JP2004182701A (ja) | ヒドロキサム酸誘導体を有効成分とする眼組織血管新生阻害剤 |